News

InteliChart Achieves Prestigious HITRUST Certification for Data Security

InteliChart Achieves Prestigious HITRUST Certification for Data Security

InteliChart Achieves HITRUST Certification

InteliChart has reached a significant milestone by securing the HITRUST Risk-based, 2-year (r2) Certification, demonstrating its unwavering dedication to robust cybersecurity and the protection of sensitive patient data. This is not just a certification; it is a testament to the company's commitment towards establishing the highest standards in information security.

The Importance of HITRUST Certification

The HITRUST r2 Certification is recognized globally as a pinnacle of information security assurance. It affirms that companies, like InteliChart, have implemented comprehensive security controls effectively. By achieving this certification, InteliChart makes it easier for potential clients to conduct due diligence, promoting a more efficient sales process and instilling confidence in its capacity to safeguard data. This not only enhances the reputation of the company but also builds trust among clients and partners.

InteliChart's Vision for Patient Data Protection

CEO Gary Hamilton emphasized the significance of this accomplishment by saying, "At InteliChart, our primary responsibility is the protection of patient data. Achieving the HITRUST r2 Certification showcases our commitment to the highest standards of data security. I'm incredibly proud of our team's collaborative effort that made this achievement possible, which further strengthens the trust our clients place in us."

Moving Towards Improved Cybersecurity Measures

InteliChart's attainment of the HITRUST r2 Certification ensures a robust framework for security that adheres to stringent regulatory standards. This not only provides clients with peace of mind regarding their data but also boosts operational efficiency. With a keen focus on providing secure and reliable patient engagement solutions, InteliChart allows healthcare providers to concentrate on delivering quality care rather than stressing over data security issues.

Expert Endorsements on HITRUST

Bimal Sheth, Executive Vice President at HITRUST, remarked on the importance of this certification by stating, "The HITRUST Assurance Program is recognized for its thoroughness, extensive control requirements, and committed oversight. The r2 Certification signifies that InteliChart is making proactive efforts towards cybersecurity and risk management."

Commitment to Data Protection Standards

Beyond the HITRUST r2 Certification, InteliChart also holds several notable certifications such as SOC 2, HITRUST Practitioner, HIPAA Security Certification, and NIST certifications. These recognitions reflect the company's ongoing commitment to maintaining superior data protection and privacy standards within the healthcare sector.

InteliChart's Contribution to Healthcare Technology

InteliChart's HITRUST r2 Certification underscores its proactive security measures which enhance its reputation as a reliable partner in the healthcare technology industry. Continuously adapting to the fast-paced digital landscape, the company remains devoted to upholding the highest levels of data protection for both healthcare providers and patients.

About InteliChart

InteliChart is renowned for its award-winning Healthy Outcomes patient-engagement platform, designed to help healthcare providers meet modern digital health expectations. Their diverse suite of solutions includes offerings such as Patient Portal, Family Portal, Patient Intake, Patient Notify, Patient Survey, Patient Schedule, Patient Activate, and Patient eHealth, making them a preferred partner for numerous EHR vendors and medical practices. With API integration spanning over 40 EHR systems, InteliChart continues to enable seamless access to its solutions, catering to the needs of over 80 million patient records.

Frequently Asked Questions

What is HITRUST Certification?

HITRUST Certification is a globally recognized standard that validates an organization's adherence to comprehensive information security requirements.

Why is HITRUST Certification important for InteliChart?

This certification enhances InteliChart's reputation by demonstrating its commitment to data security, easing the due diligence for prospective clients.

What does the HITRUST r2 Certification indicate?

The HITRUST r2 Certification indicates that InteliChart has implemented effective information security controls aligned with the highest standards.

What other certifications does InteliChart hold?

In addition to the HITRUST r2 Certification, InteliChart also holds SOC 2, HIPAA Security Certification, and NIST certifications.

What is the focus of InteliChart's patient engagement solutions?

InteliChart's solutions are designed to enhance patient engagement and facilitate healthcare providers in delivering quality care while ensuring robust data protection.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 184

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 341

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 174

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 136

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 300

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading

Top 5 Most Recently Viewed Articles

DoorDash Enters Same-Day Electronics Delivery Market

Updated Category News Views 111

Is DoorDash Changing Its Delivery Playbook? Here's the scoop: DoorDash is venturing into the electronics delivery sector, offering same-day services. We're not talking burgers or late-night sushi anymore—now it's all about those last-minute tech needs like chargers, earbuds, and monitors. It's a smart move, given our reliance on technology to stay connected and...

Continue Reading
Scarlet by RedDrop Earns Esteemed Award for Fundability

Updated Category News Views 251

Scarlet by RedDrop Recognized as a Top Fundable Company Scarlet by RedDrop, a pioneering brand in puberty and period care, has recently achieved a significant milestone. The company has been recognized as one of the Most Fundable Companies by Pepperdine Graziadio Business School, highlighting its impressive growth potential and mission-driven approach. Empowering Young...

Continue Reading
Westpac Predicts RBA's Interest Rate Cuts to Start in May 2025

Updated Category News Views 362

Westpac Forecasts RBA Rate Cuts to Commence in May 2025 According to the latest insights from Westpac, the Reserve Bank of Australia (RBA) is anticipated to start reducing interest rates from May 2025, deviating from prior expectations of an earlier cut in February. This adjustment comes as the central bank is expected to enact significant rate reductions when the easing...

Continue Reading
Innovative Pet Bed Design Revolutionizes Pet Comfort and Play

Updated Category News Views 181

Revolutionizing Pet Comfort with Unique Bed Design In a world where our pets deserve the best, one inventor has taken the initiative to create a pet bed that stands out. The LAY AND PLAY offers a distinctive design tailored especially for cats, ensuring that their needs for play and comfort are met. The inventor explained, “I wanted to invent an alternative pet bed that...

Continue Reading
Lithium Argentina Reveals Q3 2025 Insights and Future Plans

Updated Category News Views 315

Lithium Argentina's Third Quarter Highlights Lithium Argentina AG, a prominent player in the lithium sector, has recently unveiled its third quarter results for 2025. The company, recognized under the ticker symbols TSX: LAR and NYSE: LAR, showcases its ongoing commitment to improving operational performance and efficiency. Webcast and Executive Insights Today's webcast,...

Continue Reading